You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Granules Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for GRANULES, and what generic and branded alternatives to GRANULES drugs are available?

GRANULES has sixty-six approved drugs.

There is one tentative approval on GRANULES drugs.

Summary for Granules

US Patents:	0
Tradenames:	51
Ingredients:	51
NDAs:	66

Drugs and US Patents for Granules

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Granules	AMPHETAMINE SULFATE	amphetamine sulfate	TABLET;ORAL	212619-001	Aug 5, 2019	AA	RX	No	No		⤷ Subscribe				⤷ Subscribe
Granules	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	TABLET;ORAL	215771-005	Dec 28, 2021	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Granules	DEXMETHYLPHENIDATE HYDROCHLORIDE	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	213813-004	Sep 9, 2020	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Granules	RANITIDINE HYDROCHLORIDE	ranitidine hydrochloride	TABLET;ORAL	210243-001	Aug 20, 2018		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Granules	IBUPROFEN	ibuprofen	TABLET;ORAL	091625-001	Sep 15, 2015	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Granules	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	217027-003	Jan 23, 2023	AB1	RX	No	No		⤷ Subscribe				⤷ Subscribe
Granules	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	TABLET;ORAL	215771-007	Dec 28, 2021	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.